Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
48
NCT06398821
G3P-01 in Volunteers With Elevated Galectin-3
Phase: Phase 2
Role: Collaborator
Start: Oct 18, 2023
Completion: May 30, 2024